Archives

Choose a date range

From To

Choose one or more categories

Categories:



Show only original CenterWatch stories

 


Ziopharm-Intrexon collaborate with Merck Serono

Wednesday, April 1, 2015 12:50 PM

Ziopharm Oncology, a Boston, Mass.-based biotech company, and Intrexon, a synthetic biology provider, have announced their oncology programs will be strengthened through Intrexon's new global collaboration focused exclusively on novel chimeric antigen receptor T-cell (CAR-T) products with Merck Serono, the biopharmaceutical division of Merck. Intrexon will share the economic provisions of this collaboration, including upfront payment, milestones and royalties, equally with Ziopharm.

More... »

Quest Diagnostics

Aduro Biotech, Novartis collaborate on immuno-oncology products

Wednesday, April 1, 2015 12:50 PM

Aduro Biotech, a private, clinical-stage immuno-oncology company based in Berkeley, Calif., is collaborating with Novartis for the worldwide research, development and commercialization of novel immuno-oncology products derived from Aduro’s cyclic dinucleotide (CDN) approach to target the STING (Stimulator of Interferon Genes) receptor, that, when activated, is known to initiate broad innate and adaptive tumor-specific immune responses.

More... »


INC Research, SCRS award more than 100 clinical research scholarships

Wednesday, April 1, 2015 12:42 PM

INC Research, a Raleigh, N.C.-based global CRO, together with the Society for Clinical Research Sites (SCRS), an Ellicott City, Md.-based global trade organization representing clinical research sites, have collectively awarded scholarship-based memberships to more than 100 sites worldwide through the SCRS Site Scholarship Program.

More... »

The CenterWatch Monthly, April 2015

Wednesday, April 1, 2015 08:42 AM

PSI, INC Research, Chiltern best with sites

More... »

Survey: PSI, INC Research, Chiltern rated top CROs by investigative sites

Wednesday, April 1, 2015 08:00 AM

More than 1,900 global investigative sites rate the best CROs for which to work in a new survey conducted by CenterWatch, a provider of global clinical trials information. The survey results were released in the April issue of The CenterWatch Monthly newsletter.

More... »

ACRES Blue Cloud IT Platform provides shared interface for clinical researchers

Monday, March 30, 2015 02:19 PM

The Alliance for Clinical Research Excellence and Safety (ACRES), a Cambridge, Mass.-based clinical research nonprofit organization, has launched ACRES BlueCloud, the first phase implementation of a shared multi-user interface to allow sponsors, CROs, regulatory agencies, funding agencies and IRBs to access millions of verifiable professional experience and training credentials, enabling long-sought sharing and mutual recognition of those credentials by multiple stakeholders.

More... »

AcelRx restructures, reduces workforce 36%

Monday, March 30, 2015 02:17 PM

AcelRx Pharmaceuticals, a California-based specialty pharma focused on development and commercialization of innovative therapies for the treatment of acute pain, has restructured its work force as part of a plan to reduce operating costs and focus its financial and development resources on working with the FDA to seek marketing approval for Zalviso, as well as to continue the development of ARX-04.

More... »

NIH awards $9M to speed development of health technologies

Monday, March 30, 2015 02:13 PM

The NIH has selected three new proof-of-concept hubs to help speed the translation of basic biomedical discoveries into commercial products, such as new drugs, devices and diagnostics, to improve patient care and enhance health. The hubs are part of the NIH-supported Research Evaluation and Commercialization Hubs (REACH) program and will be funded $9 million over three years.

More... »

Glenn Kerkhof appointed chairman of the board

Monday, March 30, 2015 11:05 AM

George Clinical, a CRO focused on clinical development in the Asia-Pacific region, has appointed Glenn Kerkhof chairman of its board.

More... »

Why we need more older patients in clinical trials

Monday, March 30, 2015 08:00 AM

As our population ages and medical advances increase life expectancy, drug developers are facing an emerging gap in clinical research: lack of evidence to guide treatment decisions for people over 65.

More... »

CWWeekly

April 13

Quintiles-Quest Diagnostics joint venture latest in CRO-central lab deals, more could be on horizon

Biotech companies raise record amount of capital in Q1

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs